Eyelash growth from Lattise

Under the trade name Lumigan, bimatoprost was approved by the US Food and Drug Administration in December 2008. Sold as Lattise, the drug was first prescribed to control glaucoma. But this cosmetic formulation has been noticed that it can bring a side effect of eyelash growth.

An example is from a cosmetic dermatologist in California who named Lorrie Klein. He has noticed that one of his patients has beautiful and long slashes after using Lumigan for glaucoma. Currently sold in online stores and doctor’s offices, Lattise is relatively expensive that its cost ranges between $120 and $180. Nowadays, bimatoprost in a generic form is much cheaper, while ensuring the same effectiveness of eyelash growth.

Bimatoprost still has other side effects, including eyelid redness, which may cause permanent darkening of the iris. Lattise should be applied through disposable FDA-approved applicator. Although it is provided in the eye drop form, Lattise should never be applied with a cotton swab. The applicator is particularly designed to hold a drop and release it.

An increasing number of women choose to take Lattise in order to darken and thicken their eyelashes. Most of customers can realize obvious eyelash growth after a period of the treatment. The full effect of bimatoprost typically arrives in 16 weeks. Like other medications, Lattise also needs proper instruction from an eye doctor.